Skip to content
Homepage
Author:
Seer, Inc.
Posted Date:
July 2, 2026
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
Seer, Inc.
July 2, 2026
Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics
Seer, Inc.
July 1, 2026
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening
Seer, Inc.
June 22, 2026
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign
Seer, Inc.
June 15, 2026
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
Seer, Inc.
June 3, 2026
Seer Files ITC Complaint Against Nanomics
Seer, Inc.
May 29, 2026
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
Seer, Inc.
May 29, 2026
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
Seer, Inc.
May 28, 2026
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
Seer, Inc.
May 27, 2026
Seer Files Patent Infringement Lawsuit Against Nanomics
Seer, Inc.
May 27, 2026
1
2
3
Next
